NASDAQ: PHIO
Phio Pharmaceuticals Corp Stock Ownership - Who owns Phio Pharmaceuticals?

Insider buying vs selling

Have Phio Pharmaceuticals Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert J. BittermanChairman Pres CEO2025-06-102,000$2.42
$4.84kBuy
Robert L. FerraraDirector2025-06-102,500$2.42
$6.05kBuy
Robert J. BittermanChairman Pres CEO2025-06-091,500$2.75
$4.13kBuy
Robert J. BittermanChairman Pres CEO2025-05-221,200$1.78
$2.14kBuy
Robert J. BittermanChairman Pres CEO2025-05-213,000$1.77
$5.31kBuy
Robert L. FerraraDirector2025-05-202,500$1.82
$4.55kBuy

1 of 1

PHIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHIO insiders and whales buy or sell their stock.

PHIO Shareholders

What type of owners hold Phio Pharmaceuticals Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Opko Health Inc1,401.40%67,241,380$161.38MInsider
Sellas Life Sciences Group Inc675.12%32,393,095$77.74MInsider
Advanced Rna Technologies LLC25.46%1,221,723$2.93MInsider
Alexey Eliseev19.81%950,312$2.28MInsider
John A. Barrett4.65%222,991$535.18kInsider
Gerrit Dispersyn4.43%212,327$509.58kInsider
Geode Capital Management LLC0.87%41,586$99.81kInstitution
Cetera Investment Advisers0.80%38,500$92.40kInstitution
Robert J. Bitterman0.57%27,149$65.16kInsider
H. Paul Dorman0.42%20,370$48.89kInsider

1 of 3

PHIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHIO0.10%99.90%Net BuyingNet Buying
PHGE30.12%69.88%Net Buying
NERV5.55%94.45%
IMNN2.34%63.55%Net Buying
EQ24.25%40.26%Net Selling

Phio Pharmaceuticals Stock Ownership FAQ

Who owns Phio Pharmaceuticals?

Phio Pharmaceuticals (NASDAQ: PHIO) is owned by 2.10% institutional shareholders, 2,133.75% Phio Pharmaceuticals insiders, and 0.00% retail investors. Opko Health Inc is the largest individual Phio Pharmaceuticals shareholder, owning 67.24M shares representing 1,401.40% of the company. Opko Health Inc's Phio Pharmaceuticals shares are currently valued at $161.38M.

If you're new to stock investing, here's how to buy Phio Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.